lobbying_activities: 2463051

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2463051	8ec0426b-98a3-4f8a-b238-8906549e6971	Q2	THE PETRIZZO GROUP, INC.	305932	CEL-SCI CORPORATION	2020	second_quarter	MED	Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in head and neck cancer with 928 patients enrolled. LEAPS COVID-19 Immunotherapyas a new immune-based treatment for COVID-19	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Vice President of the U.S.	50000		0	0	2020-07-09T14:41:12.077000-04:00